The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II.
Tony Mok
Employment or Leadership Position - The Chinese University of Hong Kong
Consultant or Advisory Role - AstraZeneca; AVEO; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Pfizer; Roche; Taiho Pharmaceutical
Honoraria - AstraZeneca; AVEO; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - AstraZeneca
Yi Long Wu
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche; Sanofi
Sumitra Thongprasert
Consultant or Advisory Role - Lilly (U); Novartis (U); Pfizer (U)
Honoraria - AstraZeneca; Roche
Research Funding - Novartis; Pfizer; Roche
Chong-Jen Yu
Consultant or Advisory Role - AstraZeneca; Pfizer
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Roche; Sanofi
Li Zhang
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis
Research Funding - AstraZeneca; Aventis; Hengrui; Lilly; Merck Sharp & Dohme
Guia Elena Ladrera
Research Funding - Roche
Vichien Srimuninnimit
Research Funding - Roche
Virote Sriuranpong
Research Funding - Roche
Jennifer Sandoval-Tan
No relevant relationships to disclose
Yunzhong Zhu
No relevant relationships to disclose
Meilin Liao
No relevant relationships to disclose
Caicun Zhou
No relevant relationships to disclose
Hongming Pan
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis
Research Funding - AstraZeneca; Aventis; Hengrui; Lilly; Merck Sharp & Dohme
Victor Lee
No relevant relationships to disclose
Yuh-Min Chen
No relevant relationships to disclose
Yan Sun
Research Funding - AstraZeneca; AstraZeneca; Aventis; Aventis; Kanglaite Pharmaceutical ; Kanglaite Pharmaceutical ; MSD; MSD; Xiansheng; Xiansheng
Benjamin Margono
No relevant relationships to disclose
Kate Jin
Employment or Leadership Position - Roche
Other Remuneration - Roche
Matt Truman
Consultant or Advisory Role - Roche
Stock Ownership - Roche
Jin Soo Lee
Research Funding - AstraZeneca; Boehringer Ingelheim; Janssen Pharmaceutical